Structural insights into the ubiquitin-independent midnolin-proteasome pathway
- PMID: 40339123
- PMCID: PMC12088389
- DOI: 10.1073/pnas.2505345122
Structural insights into the ubiquitin-independent midnolin-proteasome pathway
Abstract
The protein midnolin (MIDN) augments proteasome activity in lymphocytes and dramatically facilitates the survival and proliferation of B-lymphoid malignancies. MIDN binds both to proteasomes and to substrates, but the mode of interaction with the proteasome is unknown, and the mechanism by which MIDN facilitates substrate degradation in a ubiquitin-independent manner is incompletely understood. Here, we present cryoelectron microscopy (cryo-EM) structures of the substrate-engaged, MIDN-bound human proteasome in two conformational states. MIDN induces proteasome conformations similarly to ubiquitinated substrates by using its ubiquitin-like domain to bind to the deubiquitinase RPN11 (PSMD14). By simultaneously binding to RPN1 (PSMD2) with its C-terminal α-helix, MIDN positions its substrate-carrying Catch domain above the proteasome ATPase channel through which substrates are translocated before degradation. Our findings suggest that both ubiquitin-like domain and C-terminal α-helix must bind to the proteasome for MIDN to stimulate proteasome activity.
Keywords: MIDN; RPN1/PSMD2; RPN11/PSMD14; UBL domain; cryo-EM.
Conflict of interest statement
Competing interests statement:The authors declare no competing interest.
References
-
- Glickman M. H., Ciechanover A., The ubiquitin-proteasome proteolytic pathway: Destruction for the sake of construction. Physiol. Rev. 82, 373–428 (2002). - PubMed
-
- Huang X. L., Luan B., Wu J. P., Shi Y. G., An atomic structure of the human 26S proteasome. Nat. Struct. Mol. Biol. 23, 778–785 (2016). - PubMed
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Miscellaneous